Published in:
01-06-2017 | Case Report
Hints for control of infection in unique extrahepatic vertebral alveolar echinococcosis
Authors:
Jean-François Faucher, Cécile Descotes-Genon, Bruno Hoen, Joël Godard, Sophie Félix, Sébastien Aubry, Oleg Blagosklonov, Frédéric Grenouillet, Marie-Pascale Brientini, Carine Richou, Solange Bresson-Hadni, Catherine Chirouze
Published in:
Infection
|
Issue 3/2017
Login to get access
Abstract
The prognosis of vertebral alveolar echinococcosis (AE) is poor. We report on the unique outcome of a patient with preexisting liver cirrhosis, in whom a diagnosis of vertebral AE was established on vertebral histopathology (D4 corporectomy in 2010 for paraplegia). Therapeutic drug monitoring of albendazole (ABZ) showed that a low dosage was appropriate. The patient recovered and ABZ withdrawal was decided in 2014, with no relapse 18 months later. In this patient, infection was purely or mainly localized in the dorsal spine, and this may have been favored by liver cirrhosis. A longer follow-up is, however, needed to confirm cure.